BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33594224)

  • 41. Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients.
    Halbgebauer R; Halbgebauer S; Oeckl P; Steinacker P; Weihe E; Schafer MK; Roselli F; Gebhard F; Huber-Lang M; Otto M
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofilament light chain level in traumatic brain injury: A system review and meta-analysis.
    Gao W; Zhang Z; Lv X; Wu Q; Yan J; Mao G; Xing W
    Medicine (Baltimore); 2020 Sep; 99(38):e22363. PubMed ID: 32957411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury.
    Clarke GJB; Skandsen T; Zetterberg H; Einarsen CE; Feyling C; Follestad T; Vik A; Blennow K; Håberg AK
    Front Neurol; 2021; 12():643743. PubMed ID: 33967940
    [No Abstract]   [Full Text] [Related]  

  • 44. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma.
    Pelinka LE; Kroepfl A; Schmidhammer R; Krenn M; Buchinger W; Redl H; Raabe A
    J Trauma; 2004 Nov; 57(5):1006-12. PubMed ID: 15580024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans.
    Lippa SM; Gill J; Brickell TA; French LM; Lange RT
    J Int Neuropsychol Soc; 2021 May; 27(5):508-514. PubMed ID: 33161932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating Brain Injury Exosomal Proteins following Moderate-To-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications.
    Mondello S; Guedes VA; Lai C; Czeiter E; Amrein K; Kobeissy F; Mechref Y; Jeromin A; Mithani S; Martin C; Wagner CL; Czigler A; Tóth L; Fazekas B; Buki A; Gill J
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
    Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury.
    Sass D; Guedes VA; Smith EG; Vorn R; Devoto C; Edwards KA; Mithani S; Hentig J; Lai C; Wagner C; Dunbar K; Hyde DR; Saligan L; Roy MJ; Gill J
    Front Pharmacol; 2021; 12():746491. PubMed ID: 34899299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated Microfluidic-Transistor Sensing System for Multiplexed Detection of Traumatic Brain Injury Biomarkers.
    Yu S; Pan Y; Tang L; Wu S; Liang C; Zhang GJ; Li YT
    ACS Sens; 2024 Jun; 9(6):3017-3026. PubMed ID: 38889364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
    Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
    J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe Traumatic Brain Injury Induces Early Changes in the Physical Properties and Protein Composition of Intracranial Extracellular Vesicles.
    Kuharić J; Grabušić K; Tokmadžić VS; Štifter S; Tulić K; Shevchuk O; Lučin P; Šustić A
    J Neurotrauma; 2019 Jan; 36(2):190-200. PubMed ID: 29690821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Traumatic Optic Nerve Injury Elevates Plasma Biomarkers of Traumatic Brain Injury in a Porcine Model.
    Bramblett GT; Harris JN; Scott LL; Holt AW
    J Neurotrauma; 2021 Apr; 38(8):1000-1005. PubMed ID: 33096971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum.
    Fraser DD; Close TE; Rose KL; Ward R; Mehl M; Farrell C; Lacroix J; Creery D; Kesselman M; Stanimirovic D; Hutchison JS;
    Pediatr Crit Care Med; 2011 May; 12(3):319-24. PubMed ID: 20625342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
    Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury.
    Carabias CS; Castaño-León AM; Blanca Navarro B; Panero I; Eiriz C; Gómez PA; Egea J; Lagares A
    J Intensive Care Med; 2020 Nov; 35(11):1180-1195. PubMed ID: 30961443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.
    Žurek J; Fedora M
    Acta Neurochir (Wien); 2012 Jan; 154(1):93-103; discussion 103. PubMed ID: 21976236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outlier Analysis for Acute Blood Biomarkers of Moderate and Severe Traumatic Brain Injury.
    Korhonen O; Mononen M; Mohammadian M; Tenovuo O; Blennow K; Hossain I; Hutchinson P; Maanpää HR; Menon DK; Newcombe VF; Sanchez JC; Takala RSK; Tallus J; van Gils M; Zetterberg H; Posti JP
    J Neurotrauma; 2024 Jan; 41(1-2):91-105. PubMed ID: 37725575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.